Dose-dependent interferon programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination
Giray Naim Eryilmaz, Yilmaz Yucehan Yazici, Radu Marcheş, Eleni P. Mimitou, Lisa Kenyon‐Pesce, Kim Handrjek, Sonia Jangra, Michael Schotsaert, Adolfo García‐Sastre, George A. Kuchel, Jacques Banchereau, Duygu Ucar
This study compares immune responses to different COVID-19 vaccines in humans, finding distinct interferon programs in myeloid cells based on vaccine type and dose timing.
bioRxiv · Aug 15, 2025 · PreprintImmunology